Cointime

TransPharma Medical

company

About

TransPharma Medical is a specialty pharmaceutical company focused on the development and commercialization of drug-products.

Highlights

Total Funding Amount
$18M
Funding Rounds
1
Investors
2

Details

Last Funding Type
Series C
Last Funding Money Raised
$18M
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2000
Operating Status
Active

TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transdermal drug delivery technology. Their current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transdermal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$18M
TransPharma Medical has raised a total of $18M in funding over 2 rounds. Their latest funding was raised on Jul 24, 2006 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 24, 2006 Series C $18M 2 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
2
TransPharma Medical is funded by 2 investors. TIF Ventures Pte and T2C2 Capital are the most recent investors.
Investor Name Lead Investor Funding Round
TIF Ventures Pte — Series C
T2C2 Capital — Series C
Cointime
เนื้อหา
บริษัท